Literature DB >> 18608056

Identification of primary HIV-1C infection in Botswana.

V Novitsky1, E Woldegabriel, C Wester, E McDonald, R Rossenkhan, M Ketunuti, J Makhema, G R Seage, M Essex.   

Abstract

Methods for identification of primary HIV infections seem increasingly important to understand pathogenesis, and to prevent transmission, which is particularly efficient during acute infection. Most current algorithms for HIV testing are based on detection of HIV antibodies and are unable to identify early infections before seroconversion. The efficiency of prospective cohorts, which is a standard approach for identifying primary HIV-1 infection, depends on a variety of epidemiological and cultural factors including HIV incidence and stigma and, not surprisingly, varies significantly in different geographical areas. We report a voluntary counseling and testing (VCT)-based approach to identifying primary HIV-1C infection that was developed as part of a primary HIV-1 subtype C infection study in Botswana. The referral strategy was based on: (1) collaboration with VCT centers at city clinics operated by the Ministry of Health; (2) partnering with the busiest non-government VCT center; (3) educating healthcare workers and the community about primary HIV infection; and (4) pairing with diverse VCT providers, including NGOs and private-sector organizations. Acute HIV-1 infections were defined by a negative HIV-1 serology combined with a positive HIV-1 RT-PCR test. Recent HIV-1 infections were identified by detuned EIA testing according to the classic STARTH algorithm. The VCT-based referral strategy resulted in the successful identification of 57 cases of acute and early HIV infection. A referral strategy of expanded VCT with viral RNA (Ribonucleic acid) testing to a national program in Botswana may be a promising approach for identification of primary HIV infections on a countrywide level. The program should offer VCT with viral RNA testing to the general public, facilitate proper counseling and risk reduction, and allow initiation of early HAART, and may reduce new viral transmissions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18608056      PMCID: PMC2605733          DOI: 10.1080/09540120701694055

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  21 in total

Review 1.  Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.

Authors:  J Steven McDougal; Christopher D Pilcher; Bharat S Parekh; Guy Gershy-Damet; Bernard M Branson; Kimberly Marsh; Stefan Z Wiktor
Journal:  AIDS       Date:  2005-05       Impact factor: 4.177

2.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

Review 3.  Surveillance for incident HIV infection: new technology and new opportunities.

Authors:  G W Rutherford; S K Schwarcz; W McFarland
Journal:  J Acquir Immune Defic Syndr       Date:  2000-12-15       Impact factor: 3.731

Review 4.  Approaching "HIV elimination": interventions for acute HIV infection.

Authors:  Christopher D Pilcher; Lisa Eaton; Seth Kalichman; Cláudia Bisol; Ricardo da Silva de Souza
Journal:  Curr HIV/AIDS Rep       Date:  2006-11       Impact factor: 5.071

5.  HIV incidence among repeat HIV testers at a county hospital, San Francisco, California, USA.

Authors:  T A Kellogg; W McFarland; J L Perlman; H Weinstock; S Bock; M H Katz; J L Gerberding; D R Bangsberg
Journal:  J Acquir Immune Defic Syndr       Date:  2001-09-01       Impact factor: 3.731

6.  Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco.

Authors:  W McFarland; M P Busch; T A Kellogg; B D Rawal; G A Satten; M H Katz; J Dilley; R S Janssen
Journal:  J Acquir Immune Defic Syndr       Date:  1999-12-15       Impact factor: 3.731

7.  Differences in the temporal trends of HIV seroincidence and seroprevalence among sexually transmitted disease clinic patients, 1989-1998: application of the serologic testing algorithm for recent HIV seroconversion.

Authors:  S Schwarcz; T Kellogg; W McFarland; B Louie; R Kohn; M Busch; M Katz; G Bolan; J Klausner; H Weinstock
Journal:  Am J Epidemiol       Date:  2001-05-15       Impact factor: 4.897

8.  High rates of forward transmission events after acute/early HIV-1 infection.

Authors:  Bluma G Brenner; Michel Roger; Jean-Pierre Routy; Daniela Moisi; Michel Ntemgwa; Claudine Matte; Jean-Guy Baril; Rejéan Thomas; Danielle Rouleau; Julie Bruneau; Roger Leblanc; Mario Legault; Cecile Tremblay; Hugues Charest; Mark A Wainberg
Journal:  J Infect Dis       Date:  2007-02-16       Impact factor: 5.226

9.  Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.

Authors:  B S Parekh; C P Pau; M S Kennedy; T L Dobbs; J S McDougal
Journal:  AIDS Res Hum Retroviruses       Date:  2001-01-20       Impact factor: 2.205

10.  Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.

Authors:  B S Parekh; D J Hu; S Vanichseni; G A Satten; D Candal; N L Young; D Kitayaporn; L O Srisuwanvilai; S Rakhtam; R Janssen; K Choopanya; T D Mastro
Journal:  AIDS Res Hum Retroviruses       Date:  2001-03-20       Impact factor: 2.205

View more
  26 in total

1.  Evolutionary gamut of in vivo Gag substitutions during early HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Rui Wang; Jeannie Baca; Lauren Margolin; Mary F McLane; Sikhulile Moyo; Erik van Widenfelt; Joseph Makhema; M Essex
Journal:  Virology       Date:  2011-10-19       Impact factor: 3.616

2.  Cohort Profile: The Likoma Network Study (LNS).

Authors:  Stéphane Helleringer; James Mkandawire; Linda Kalilani-Phiri; Hans-Peter Kohler
Journal:  Int J Epidemiol       Date:  2013-03-28       Impact factor: 7.196

3.  Dynamics and timing of in vivo mutations at Gag residue 242 during primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Rui Wang; Lauren Margolin; Jeannie Baca; Sikhulile Moyo; Rosemary Musonda; M Essex
Journal:  Virology       Date:  2010-05-04       Impact factor: 3.616

4.  Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Elias Woldegabriel; Lemme Kebaabetswe; Raabya Rossenkhan; Busisiwe Mlotshwa; Caitlin Bonney; Mariel Finucane; Rosemary Musonda; Sikhulile Moyo; Carolyn Wester; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

5.  Sample size considerations in the design of cluster randomized trials of combination HIV prevention.

Authors:  Rui Wang; Ravi Goyal; Quanhong Lei; M Essex; Victor De Gruttola
Journal:  Clin Trials       Date:  2014-06       Impact factor: 2.486

6.  Intra-host evolutionary rates in HIV-1C env and gag during primary infection.

Authors:  Vlad Novitsky; Rui Wang; Raabya Rossenkhan; Sikhulile Moyo; M Essex
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

7.  Phylodynamic analysis of HIV sub-epidemics in Mochudi, Botswana.

Authors:  Vlad Novitsky; Denise Kühnert; Sikhulile Moyo; Erik Widenfelt; Lillian Okui; M Essex
Journal:  Epidemics       Date:  2015-08-28       Impact factor: 4.396

8.  HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission.

Authors:  Vladimir Novitsky; Rui Wang; Hermann Bussmann; Shahin Lockman; Marianna Baum; Roger Shapiro; Ibou Thior; Carolyn Wester; C William Wester; Anthony Ogwu; Aida Asmelash; Rosemary Musonda; Adriana Campa; Sikhulile Moyo; Erik van Widenfelt; Madisa Mine; Claire Moffat; Mompati Mmalane; Joseph Makhema; Richard Marlink; Peter Gilbert; George R Seage; Victor DeGruttola; M Essex
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

9.  tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

Authors:  Raabya Rossenkhan; Iain J MacLeod; Theresa K Sebunya; Eduardo Castro-Nallar; Mary Fran McLane; Rosemary Musonda; Berhanu A Gashe; Vlad Novitsky; M Essex
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Timing constraints of in vivo gag mutations during primary HIV-1 subtype C infection.

Authors:  Vladimir Novitsky; Rui Wang; Lauren Margolin; Jeannie Baca; Lemme Kebaabetswe; Raabya Rossenkhan; Caitlin Bonney; Michaela Herzig; David Nkwe; Sikhulile Moyo; Rosemary Musonda; Elias Woldegabriel; Erik van Widenfelt; Joseph Makhema; Stephen Lagakos; M Essex
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.